(Q42984097)

12 November 2017

Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope (English)

1 reference

12 November 2017

1 reference

1 reference

6

1 reference

12 November 2017

Kaneko T

1

1 reference

12 November 2017

Moriyama T

2

1 reference

12 November 2017

Udaka K

3

1 reference

12 November 2017

Hiroishi K

4

1 reference

12 November 2017

Kita H

5

1 reference

12 November 2017

Yagita H

7

1 reference

12 November 2017

Okumura K

8

1 reference

12 November 2017

Imawari M

9

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

European Journal of Immunology

12 November 2017

1 reference

12 November 2017

27

1 reference

12 November 2017

1782-1787

1 reference

12 November 2017

7

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Rapid evolution of RNA genomes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Specificity and flexibility in thymic selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

T cell receptor antagonist peptides induce positive selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.1830270728

1 reference

7 January 2021

Antagonists or altruists: do viral mutants modulate T-cell responses?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

The in vitro response to sheep erythrocytes by mouse spleen cells: Segregation of distinct events leading to antibody formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270728

7 January 2021

Identifiers

DOI

10.1002/EJI.1830270728

1 reference

release_kwsow5rnwrc7xmcrwb33sdkmdq

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kwsow5rnwrc7xmcrwb33sdkmdq

24 November 2022

mapped directly with Wikidata item

1 reference